Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Soy protein health claim

This article was originally published in The Tan Sheet

Executive Summary

On behalf of the soybean producing industry, Rep. Ed Bryant (R-Tenn.) sends letter to FDA Commissioner Jane Henney, MD, Jan. 11 supporting the agency's Nov. 10 proposed rule allowing a heart disease risk reduction claim for soy protein products ("The Tan Sheet" Nov. 16, 1998, p. 4). Co-signed by more than 40 members of Congress, the letter notes the Soybean Industry Coalition has completed 46 clinical studies demonstrating the substance "significantly reduces" total LDL cholesterol without affecting beneficial HDL-cholesterol, and the "evidence weighs strongly in favor of soy protein with naturally occurring isoflavones as being the agent of the observed lipid-lowering effects." The comment period of the proposal closes Jan. 25
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS089310

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel